Harmony Biosciences Holdings (HRMY) Amortizatization of Intangibles (2023 - 2026)
Harmony Biosciences Holdings (HRMY) reported Amortizatization of Intangibles of $220000.0 for Q1 2026, down 51.22% on a YoY basis from $451000.0 in Q1 2025, and down 21.71% sequentially from $281000.0 in Q4 2025.
Harmony Biosciences Holdings (HRMY) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends
Harmony Biosciences Holdings (HRMY) has 4 years of Amortizatization of Intangibles data on file, last reported at $220000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles fell 51.22% year-over-year to $220000.0; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (down 39.09% YoY), and the FY2025 full-year result was $1.5 million, down 32.73% from the prior year.
- Amortizatization of Intangibles retreated to $220000.0 in Q1 2026, from $281000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $719000.0 in Q3 2023 to a low of $220000.0 in Q1 2026.
- A 4-year average of $516692.3 and a median of $550000.0 in 2024 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles fell 6.6% in 2024 and slumped 51.22% in 2026, its largest moves.
- Tracing HRMY's Amortizatization of Intangibles over 4 years: stood at $684000.0 in 2023, then slipped by 28.22% to $491000.0 in 2024, then sank by 42.77% to $281000.0 in 2025, then decreased by 21.71% to $220000.0 in 2026.
- Business Quant data shows HRMY's Amortizatization of Intangibles at $220000.0 in Q1 2026, $281000.0 in Q4 2025, and $336000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Harmony Biosciences Holdings | 2.09 Bn | 1.57 Bn | 170.88 Mn | 220,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 220,000.00 |
| Mar 31, 2026 | 220,000.00 |
| Dec 31, 2025 | 281,000.00 |
| Dec 31, 2025 | 281,000.00 |
| Sep 30, 2025 | 336,000.00 |
| Sep 30, 2025 | 336,000.00 |
| Jun 30, 2025 | 453,000.00 |
| Jun 30, 2025 | 453,000.00 |
| Mar 31, 2025 | 451,000.00 |
| Mar 31, 2025 | 451,000.00 |
| Dec 31, 2024 | 491,000.00 |
| Dec 31, 2024 | 491,000.00 |
| Sep 30, 2024 | 550,000.00 |
| Sep 30, 2024 | 550,000.00 |
| Jun 30, 2024 | 626,000.00 |
| Jun 30, 2024 | 626,000.00 |
| Mar 31, 2024 | 594,000.00 |
| Mar 31, 2024 | 594,000.00 |
| Dec 31, 2023 | 684,000.00 |
| Dec 31, 2023 | 684,000.00 |